Realist evaluation of the role of the Universal Health Coverage Partnership in strengthening policy dialogue for health planning and financing: A protocol by Robert, Emilie et al.
1Robert E, et al. BMJ Open 2019;9:e022345. doi:10.1136/bmjopen-2018-022345
Open access 
Realist evaluation of the role of the 
Universal Health Coverage Partnership in 
strengthening policy dialogue for health 
planning and financing: a protocol
Emilie Robert,1 Valery Ridde,2,3 Dheepa Rajan,4 Omar Sam,5 Mamadou Dravé,6 
Denis Porignon4
To cite: Robert E, Ridde V, 
Rajan D, et al.  Realist evaluation 
of the role of the Universal 
Health Coverage Partnership in 
strengthening policy dialogue 
for health planning and 
financing: a protocol. BMJ Open 
2019;9:e022345. doi:10.1136/
bmjopen-2018-022345
 ► Prepublication history for 
this paper is available online. 
To view these files, please visit 
the journal online (http:// dx. doi. 
org/ 10. 1136/ bmjopen- 2018- 
022345).
Received 7 March 2018
Revised 8 October 2018
Accepted 19 October 2018
For numbered affiliations see 
end of article.
Correspondence to
Dr Emilie Robert;  
 emilie. robert2@ mail. mcgill. ca
Protocol
© Author(s) (or their 
employer(s)) 2019. Re-use 
permitted under CC BY. 
Published by BMJ.
AbstrACt
Introduction In 2011, WHO, the European Union and 
Luxembourg entered into a collaborative agreement to 
support policy dialogue for health planning and financing; 
these were acknowledged as core areas in need of 
targeted support in countries’ quest towards universal 
health coverage (UHC). Entitled ‘Universal Health Coverage 
Partnership’, this intervention is intended to strengthen 
countries’ capacity to develop, negotiate, implement, 
monitor and evaluate robust and integrated national health 
policies oriented towards UHC. It is a complex intervention 
involving a multitude of actors working on a significant 
number of remarkably diverse activities in different 
countries.
Methods and analysis The researchers will conduct a 
realist evaluation to answer the following question: How, in 
what contexts, and triggering what mechanisms, does the 
Partnership support policy dialogue for health planning and 
financing towards UHC? A qualitative multiple case study 
will be undertaken in Togo, Liberia, Democratic Republic 
of Congo, Cape Verde, Burkina Faso and Niger. Three steps 
will be implemented: (1) formulating context–mechanism–
outcome explanatory propositions to guide data collection, 
based on expert knowledge and theoretical literature; 
(2) collecting empirical data through semistructured 
interviews with key informants and observations of key 
events, and analysing data; (3) specifying the intervention 
theory.
Ethics and dissemination The primary target audiences 
are WHO and its partner countries; international and 
national stakeholders involved in or supporting policy 
dialogues in the health sector, especially in low-income 
countries; and researchers with interest in UHC, policy 
dialogue, evaluation research and/or realist evaluation.
IntroduCtIon 
Universal health coverage (UHC) as a core 
objective within the Sustainable Develop-
ment Goals is a journey in which multiple 
stakeholders, from the local, national and 
international levels, partake. It involves 
ongoing discussions and negotiations among 
these stakeholders on the different facets of 
UHC, among which financing and planning 
questions.1 2 Under the leadership of national 
health authorities, stakeholders will thus have 
to agree on priorities for action, and health 
financing and health system organisation 
modalities.
Policy dialogue is where such discussions 
take place. WHO describes policy dialogue 
as an iterative process that targets both the 
technical and policy aspects of the problem 
being discussed, involving evidence and sensi-
tive policy discussions, in which a wide range 
of stakeholders participate.3 This dialogue 
has a concrete objective, such as the develop-
ment of a plan, a strategy or a policy. Policy 
dialogue is thus understood as a deliberative 
process by which different stakeholders are 
brought together to discuss issues of public 
policy to feed into decision-making.
In low-income and middle-income country 
(LMIC) settings, the topic area of policy 
dialogue is attracting interest as a target 
strengths and limitations of this study
 ► The in-depth study of six countries ensures internal 
validity, and the potential to generalise the findings 
is increased by building explanations, taking the 
context into account in the production of outcomes 
and using existing literature to provide theoretical 
foundations to the findings.
 ► Methodological developments are expected, as the 
study is among the few realist evaluations to focus 
on policy dialogue, especially in low-income and 
middle-income countries.
 ► The study involves training and ongoing supervision 
of West African researchers who come from a differ-
ent educational background, contributing to capaci-
ty building in health policy and systems research in 
low-income and middle-income countries.
 ► The study does not include countries or cases out-
side of the West African region.
 ► Comprehensive data collection may be challenging 
in some countries with an unstable political situation.
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intervention for programmes. Policy dialogue is seen as 
a key governance tool to ensure the coordination and 
alignment of stakeholders and to develop robust and 
comprehensive health policies anchored in the UHC 
concept.4 Negotiations in the health sector may indeed 
be challenging due to the heavy influence external aid 
can have on national priorities, combined with the often 
limited government steering capacity to counterbalance 
that influence.5 6 In the context of UHC, Ministries of 
Health’s convening and brokering role takes on an added 
layer of importance, as they need to bring together a 
diverse range of interests to mobilise resources, prioritise 
interventions and strengthen institutions for UHC.
Following this trend, policy dialogue is becoming a 
popular research object.7 In the field of health policy and 
systems research in LMICs, scholars study policy dialogue 
as a knowledge translation instrument8–11 or as a deci-
sion-making process. In this case, they notably study the 
perceptions of what policy dialogue is.12–14 The actual 
process of policy dialogue is more rarely investigated.15 16 
In high-income countries, research on policy dialogue 
as part of decision-making is more diffuse and includes 
research on research-policy dialogue,17 18 stakeholder 
dialogue19 20 or social dialogue.21
In 2011, WHO, the European Union and Luxem-
bourg entered into a collaborative agreement called the 
Universal Health Coverage Partnership to support policy 
dialogue for health planning and financing as core topic 
areas of UHC. This Partnership also responds to a reso-
lution from the 64th World Health Assembly calling on 
WHO to support countries in developing more robust 
and evidence-based health policies and plans based on 
an inclusive and participatory process.22 Implemented in 
28 countries, the Partnership is a complex intervention 
involving a multitude of actors working on a significant 
number of very diverse activities in different countries. 
Moreover, it takes place in the policy arena where poli-
cy-making is complex and dynamic. This study aims to 
examine the Partnership through a realist lens, to better 
understand how and in what contexts it can, through 
WHO in-country support, contribute to strengthening 
policy dialogue.
realist approach
Traditional evaluation methods face three limitations 
when studying complex interventions in dynamic 
contexts, as is the case of the Partnership. First, estab-
lishing a causal relationship between the Partnership and 
its expected outcomes in terms of policy formulation and 
donors alignment on one hand, and between the Part-
nership and the indicators usually used in classical eval-
uations on the other, is onerous as such relationships 
are not direct and are strongly coloured by the contexts 
within which WHO intervenes. Second, WHO’s role in 
the Partnership complements its traditional role as tech-
nical advisor. Demonstrating how this new approach helps 
support policy dialogue, and painting a clear picture of 
the challenges involved, is difficult to do using traditional 
evaluation methods. Finally, the Partnership has been 
implemented in several countries representing a wide 
variety of contexts, which raises the third limitation of 
traditional evaluations: the inability to take context into 
account in explaining an intervention’s outcomes and to 
draw parallels between the experiences of different coun-
tries. Therefore, the realist approach was deemed most 
appropriate as a frame to evaluate the UHC Partnership.
A realist evaluation entails the premise that an inter-
vention does not function on its own and is not, in itself, 
what produces an outcome.23 Instead, an outcome is the 
product of the interaction between a mechanism trig-
gered by the intervention and the context in which the 
intervention is implemented. A mechanism should be 
understood as the way in which the actors involved in 
an intervention react to and reason about the resources 
made available to them as part of the intervention.24
A realist evaluation, therefore, does not attempt to 
control the variables associated with the implementation 
context. Rather, it seeks to observe, in the natural envi-
ronment, the regular—although not systematic—occur-
rence of an outcome in a particular context, when a 
mechanism is triggered. These iterations of interactions 
are referred to as context–mechanism–outcome (CMO) 
configurations. The objective of a realist evaluation is 
thus to identify, in the empirical data, iterative interac-
tions between an intervention’s context, mechanisms 
and outcomes. Operationally, it begins with a reflection 
on the intervention theory and results in the production 
of an explanatory theory, which is sufficiently abstract 
to explain how the intervention functions in different 
contexts. This anchoring in theory requires an explicitly 
iterative process between the conceptual and theoretical 
literature underlying the rationale behind the interven-
tion, and the empirical data.
Intervention theory
Several sources of information were used to develop an 
initial intervention theory of the Partnership. In addition 
to reviewing the documents produced by WHO, several 
meetings were held with stakeholders from WHO head-
quarters’ Department of Health Systems Governance 
and Financing which implements the Partnership. These 
meetings aimed to make explicit the logical reasoning 
underlying the need for and the rationale behind the 
Partnership. Observations of two annual intercountry 
meetings bringing together partner countries and WHO 
teams were also conducted. This process resulted in a 
generic intervention theory that was discussed at a work-
shop in Burkina Faso in 2017 and subsequently adjusted 
to take into account the participants’ input (figure 1).
In the frame of the Partnership, WHO supports policy 
dialogue processes for health planning and health 
financing. According to WHO, such processes should 
be inclusive and participatory, fed by knowledge and 
evidence, and led by the Ministries of Health (MoH). 
WHO’s role is to support MoH to lead structured and 
transparent policy dialogues. The ultimate goal is to 
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contribute to strengthening health systems, especially 
its governance function, with the assumption that health 
systems strengthening is the principal means to achieve 
UHC. WHO support through the Partnership manifests 
itself through a hard component, including financial 
resources for a set of activities as well as human resources, 
and a soft component, which refers to a specific approach 
to supporting the policy dialogue. The hard component 
of WHO support includes strengthening of the capaci-
ties of MoH to conduct policy dialogue processes. This 
involves WHO country office ongoing support as well as 
training. It also involves strengthening of the quality of 
the policy dialogue itself with the generation of relevant 
evidence, data and normative guidelines, as well as ad hoc 
expertise. With regard to WHO’s approach, three charac-
teristics are essential: flexibility, that is, the ability to adapt 
to the changing priorities of the MoH; responsiveness, 
or the ability to position and respond to requests from 
the MoH; and proactivity, that is, the ability to anticipate 
implementation steps and expectations or needs of the 
MoH.
The resulting policy dialogue is expected to enable 
the formulation of robust and comprehensive health 
policies, strategies and plans that promote the principles 
of UHC such as equity, financial risk protection and 
quality of care. It should also facilitate the alignment 
of multiple stakeholders, be they donors, civil society 
or related ministries. Thus, the Partnership is supposed 
to contribute to upholding the principles of the Paris 
Declaration to ensure effective development coopera-
tion. Finally, supporting MoH in the organisation of such 
dialogues is expected to strengthen the capacities and 
leadership position of the MoH. To summarise, WHO has 
three principal roles within the Partnership: convener of 
policy dialogue processes, policy broker and a relatively 
traditional role of advisor to the MoH.
WHO may act as a ‘boundary spanner’, that is, an actor 
who brings together partners with common interests and 
goals (such as UHC), while striving to establish a climate 
of trust, optimism and perseverance.25 The concept of 
policy broker is similar to that of boundary spanner. The 
role of a broker is to bring together groups of actors whose 
interests and beliefs differ about the issue of concern in 
the policy dialogue.26 The broker’s objective is to promote 
consensus in a climate of trust, to stabilise the policy 
dialogue and to find workable compromises. However, 
his role is not necessarily a disinterested one, and he 
might be pursuing a strategic objective, which would 
Figure 1 Generic intervention theory of the Universal Health Coverage Partnership. MoH, Ministries of Health.
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bring him closer to the role of a policy entrepreneur. A 
policy entrepreneur has an explicit strategic objective, 
and proposes ideas and stimulates opportunities in ways 
that are intended to create a demand for the solution he 
is proposing.26 These roles are, however, ideal types posi-
tioned at two ends of a continuum.26 Depending on the 
contexts in which it intervenes, the processes in which it 
is involved and the issues being discussed, WHO may be 
called on to play one or another of these various roles.
MEthods And AnAlysIs
research questions
The question that will guide the study is: How, in what 
contexts, and triggering what mechanisms, does the Part-
nership support policy dialogue for health planning and 
health financing towards UHC, and with what outcomes?
Four specific objectives have been established to 
respond to this research question:
1. To highlight the contexts in which the Partnership, 
through WHO support, can, or cannot:
a. act as a broker, promoting the dissemination and 
use of data and evidence in policy dialogue and 
seeking workable compromises;
b. act as a convener, creating synergy among the actors 
involved in policy dialogue for health planning and 
financing;
c. play its role as an advisor, ensuring transparent and 
structured policy dialogue in accordance with avail-
able evidence and equity principles; and supporting 
MoH in its leadership and stewardship functions.
2. To identify the mechanisms at work and the out-
comes—direct or indirect, expected or not—pro-
duced;
3. To clarify the process chains and the links between 
them, especially highlighting feedback loops;
4. To specify how, in what contexts, triggering what 
mechanisms and with what outcomes the Partnership, 
through WHO support, enhances policy dialogue for 
health planning and financing towards UHC.
study design
A realist multiple case study will be undertaken.27 Table 1 
presents a summary of the proposed design. The coun-
tries in which the study will be conducted are Togo, 
Liberia, Democratic Republic of Congo, Cape Verde, 
Burkina Faso and Niger. Due to feasibility concerns, only 
partner countries of the African continent were selected. 
They were sampled using a non-probabilistic approach. 
The objective was to select cases—or countries—purpo-
sively, so as to obtain a diversity and depth of information 
on the Partnership. This is therefore a contrasted sample. 
When selecting cases, purposive sampling involves estab-
lishing selection criteria that ensure contrasting cases. 
The criteria are based on theoretical assumptions about 
the influence they may have on the Partnership and 
policy dialogue. An initial list was shared with WHO in 
order to select the criteria that could be informed by 
their experience. Based on their country knowledge and 
experience, they then suggested countries matching the 
criteria, based on their country knowledge and experi-
ence (table 2).
Each country has a roadmap for the Partnership work, 
in line with its needs. In this study, the unit of analysis is a 
policy dialogue process defined in the country’s roadmap. 
One process (unit of analysis) will be observed in each 
country (case). Each process was selected in collabora-
tion with the country teams, taking into account ongoing 
support at the start of data collection, as well as oppor-
tunities for observation. In Burkina Faso and DRC, the 
processes under study are the policy dialogues around 
the national health financing strategy, whereas in Cape 
Verde, Niger and Togo, there are the policy dialogues for 
the elaboration of the national or regional health plans. 
In Liberia, the process under study is the elaboration of 
the IHP+ (International Health Partnership) Compact, 
which is an aid coordination agreement among health 
sector stakeholders. The process selected determines the 
research subquestions to be addressed in each case, the 
documentation to be obtained, the informants to inter-
view, and the topics to be covered in interviews.
study steps
Step 1: formulating CMO propositions
Within a realist perspective, researchers raise the ques-
tions of the mechanisms, that is, how actors react to the 
new resources made available through an intervention, 
and of the contexts that trigger or hinder these mech-
anisms. The initial intervention theory was divided into 
two subtheories to clarify what mechanisms and contexts 
may interact (figure 2 and figure 3). Contexts and mech-
anisms derive from three sources: literature on partner-
ship synergy25 28 29; a scoping study on policy dialogue,30 
looking into knowledge translation, policy change and 
development studies literature; and interviews conducted 
with international experts involved in the Partnership. 
We describe below both subtheories, highlighting mech-
anisms (M), outcomes (O) and potential contexts (C).
The first subtheory focuses on the Partnership and 
its expected outcomes (figure 2). It posits that capacity 
building, through training, technical expertise and 
ongoing support from WHO, would empower MoH (M), 
while triggering a shared understanding of governance 
Table 1 Summary of the study design 
Epistemological foundation Critical realism
Design Multiple case studies
Cases Countries involved in the 
Partnership
Units of analysis Policy dialogue processes 
supported by WHO as part of 
the country roadmaps
Type of sample Contrasted
Case sampling strategy Purposive sampling
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and policy dialogue (M). This should result in MoH 
leading inclusive and participatory policy dialogues 
(O). Furthermore, the ongoing support provided to 
MoH, combined with WHO approach (ie, proactiveness, 
responsiveness, flexibility), should prompt mutual trust 
(M), which in turn should strengthen their collaboration 
for policy dialogues (O). Finally, the subtheory postu-
lates that the availability of evidence and data provided 
through the Partnership would bring about a shared 
understanding of the needs and policy options by MoH 
Figure 2 Initial subtheory of the Universal Health Coverage Partnership (subtheory 1). MoH, Ministries of Health.
Table 2 Case selection criteria and reason for sampling
Criteria* Togo Liberia DRC Cape Verde Burkina Faso Niger
Duration of WHO support 4 4 3 3 3 3
Political stability
(0=instable; 4=stable)
3 3 2 3 3 1.5
Ministerial stability (0=instable; 4=stable) 3 3 3 2 2 1
Openness to policy dialogue
(0=not open; 4=open)
3 3 3 2 2 1.5
Ministry of Health leadership capacity 
(0=weak; 4=strong)
3 3 3 3 3 1.5
Implementation of the national roadmap 
(0=weak; 4=good)
3 3 3 2 3 1
Presence of entry points Yes Yes Yes Yes Yes Yes




Criteria were noted on a scale from 0 to 4, where 0 is the lowest and 4 the highest. For example, a score of 4 for Togo for criteria ‘Duration of 
WHO support’ means that the country benefited from WHO support for the longest period of time.
*At the time of case selection. 
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and WHO (M), contributing to an evidence-informed 
policy dialogue (O). In subtheory 1, mechanisms may 
be triggered by the Partnership when existing national 
governance arrangements facilitate the organisation of 
policy dialogue (C); WHO and MoH have enduring rela-
tionships (C); they have the expected expertise and skills 
(C); they both endorse collaborative and cross-sectoral 
ways of working (C); human resources from both institu-
tions who are involved in the Partnership are stable (C); 
and there is synergy between the Partnership and inter-
national stakeholders’ priorities and plans to strengthen 
MoH leadership (C).
The second subtheory focuses on policy dialogue 
and its expected outcomes (figure 3). It posits that 
an evidence-informed policy dialogue would first 
trigger a shared understanding among stakeholders of 
the challenges and possible ways of action (M). This 
should contribute to more robust and comprehensive 
health policies, strategies and plans (O) through the 
formulation of commonly agreed workable proposi-
tions. An inclusive and participatory policy dialogue 
should also prompt a shared understanding of stakes, 
values  and interests of the various actors involved (M), 
as well as buy-in of the decisions (M), strengthening 
stakeholders’ alignment on national health priori-
ties (O). Finally, brought under the responsibility of 
MoH, it should foster MoH sense of ownership of the 
process (M), contributing to strengthening its lead-
ership (O). Such an outcome may also be the conse-
quence of stakeholders’ trust in a structured and 
transparent policy dialogue process (M). In subtheory 
2, policy dialogue may trigger such mechanisms when 
participants show openness to policy dialogue (C); 
they have the capacity and legitimacy to actively partic-
ipate (C); they have previous positive experience of 
policy dialogue (C); their organisations’ culture value 
collaboration and cross-sectoral ways of working (C); 
policy dialogue benefit from financial and technical 
support (eg, the Partnership) (C); there is synergy 
between the global and national health agendas (C); 
and policy dialogue matches sociocultural forms of 
communication and participation to governance and 
formal events (C).
For each case, we will formulate at least one CMO 
proposition for each outcome, based on these theories. 
Additional theoretical literature may be used to fill in 
potential knowledge gaps, such as capacity building 
literature and theories about organisational change.
Figure 3 Initial subtheory of policy dialogue (subtheory 2). MoH, Ministries of Health.
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Step 2: collecting and analysing empirical data
Once the propositions are developed, an interview guide 
will be drafted for each case. The interviewee is there to 
help the researcher ‘refine’ the theory, as each interviewee 
holds a piece of the complex puzzle of the intervention.23 
Consequently, the interview guide will be adjusted to 
the interviewee. For example, it is expected that WHO 
informants will be knowledgeable about the Partnership 
and its outcomes (subtheory 1), while other stakeholders 
will be able to share their experience as policy dialogue 
participants (subtheory 2).
Three sources of information will be used. First, semi-
structured interviews will be conducted with key infor-
mants who will be jointly identified by the researchers and 
WHO. An initial list will be compiled by WHO and then 
supplemented using a snowballing technique. The aim is 
to meet with as many as possible of the participants of the 
policy dialogue and avoid investigating merely the posi-
tive side of the coin, and thus possible bias. Depending on 
informants’ availability, interviews will be conducted in 
person or by telephone. The interviews will be audio-re-
corded, except when not allowed by the participants. 
They will also be recorded in notes taken systematically 
by the researchers. Recordings will subsequently be tran-
scribed. Between 20 and 30 informants will be interviewed 
for each case. The principle of empirical saturation will 
be applied to determine the best time to bring the data 
collection to a close.31
Observations will also be conducted of activities organ-
ised either directly by WHO or with WHO collaboration 
within the Partnership context. These observations will be 
described and recorded in the logbooks of researchers. 
Also, all documentation related to the Partnership (eg, 
national roadmaps, project documents, annual reports) 
will be reviewed.
Furthermore, to gain a deeper understanding of the 
national health policy contexts, and particularly of the 
interests, power relationships and positioning of the 
actors involved in policy dialogue, a stakeholder analysis 
will be performed for each case.32 First, we will compile 
a list of stakeholders involved in policy dialogue for 
each case. Then, for each stakeholder, we will attempt 
to describe their power of action and influence, as well 
as their interest and involvement with respect to UHC 
and policy dialogue. The last step will be to analyse how 
these stakeholders react to the roles played by WHO in 
policy dialogue and how their reactions influence these 
two processes. This exercise will be conducted before the 
interviews in collaboration with the WHO teams, who 
have first-hand knowledge of the field. The analysis will 
be completed during the interviews with the stakeholders 
included on the list.
Using an iterative approach during data collection, 
we will deepen our understanding of the intervention 
theory, including ‘hypotheses about their subjects’ 
reasoning within a wider model of their causes and 
consequences’ (p. 163).23 Data analysis will contribute to 
deepening our understanding further. It will start with a 
thorough description of the barriers and facilitators for 
each piece of the intervention theory. We will then move 
to identify in the data the interaction between context, 
mechanisms and outcomes. Finally, we will attempt to 
identify—across interviews—patterns of such interac-
tions, called CMO configurations. Both barriers and 
facilitators and CMO configurations will be identified 
in the data through content analysis performed using 
NVivo software. For the latter, we will (1) identify the 
outcomes (description), (2) determine the contextual 
components related to the outcomes (resolution), (3) 
reconstruct the links between context and outcomes 
theoretically (abduction), and (4) identify the mecha-
nisms (retroduction).33 Retroduction aims to construct 
the theoretical explanation of a phenomenon.34 35 More 
specifically, this retrospective reasoning allows moving 
from describing the outcome to describing what 
produced that outcome and the context within which 
Table 3 Summary of the study process
Steps Data sources Methods Status
Building a generic 
intervention theory
 ► Programme documents
 ► Meetings with stakeholders from WHO headquarters’ 
Department of Health Systems Governance and Financing








 ► Literature review on policy dialogue
 ► Semistructured interviews with experts at WHO headquarters 
and at regional level (n=13)
 ► Scoping study





 ► Semistructured interviews with WHO national experts, MoH 
counterparts, participants of policy dialogues (eg, civil society, 
international stakeholders, connected Ministries and public 
institutions) in each country
 ► Observations of policy dialogues
 ► Stakeholder analysis




 ► CMO configurations from cases Transversal analysis 2019
CMO, context–mechanism–outcome; MoH, Ministries of Health.
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it takes place,36 37 via the mechanisms.38 In case of 
missing pieces of evidence, additional interviews will be 
conducted whenever possible.
Step 3: specifying the theory
In order to specify the intervention theory across cases, a 
transversal analysis will be conducted using CMO config-
urations as primary data. Such configurations may be 
incomplete, with the mechanism generally not being 
explicit. The missing links will thus be inferred from the 
theoretical literature, which provides clues to explain the 
links between causes and outcomes, following a process 
of intellectual reasoning based on two questions: How 
can we explain the mechanism in this context and consid-
ering this outcome? Is this interpretation supported by 
the theoretical literature?
This inference takes the form of a demi-regularity when 
the configuration re-appears several times. A demi-regu-
larity is a regular—although not systematic—occurrence 
in the interactions among the context, the mechanism(s) 
and the outcomes.39 When a configuration is identi-
fied only once but its interpretation is supported by 
the theoretical literature, it is also taken into account, 
on the condition that it helps to clarify how and under 
what circumstances the Partnership contributes to each 
outcome. Each demi-regularity will provide one or more 
piece of information that, when combined, present a 
more complete and precise picture of the Partnership. 
Such an analysis will contribute to specify the explanatory 
realist theory of the Partnership. Table 3 summarises the 
study process, including sources of data, methods and 
status. The research should be completed by mid-2019.
Patients and public involvement
There is no patient or public involvement in this study.
EthICs And dIssEMInAtIon
Protection of key informants
The research objectives and a consent form will be sent 
by email to informants before the interviews. The rights 
of informants include the right to refuse to participate 
in the interview, to end their participation in the study at 
any time and to not allow their statements to be audio-re-
corded. Informed consent will be sought in writing from 
informants. We expect that all informants will be literate, 
given that they occupy positions of responsibility.
Informants’ statements will be kept confidential. The 
data collected will be kept anonymous at the time of tran-
scription, that is, informants’ names will be concealed, 
as well as their title and their function. Transcriptionists 
and everyone involved in data collection and analysis will 
sign confidentiality agreements. A copy of the data will 
be maintained on a password-protected virtual platform. 
The data will be destroyed 18 months after the signing of 
the consent forms.
Importance of the study
First, in providing lessons on how the Partnership works 
and what proximal and unexpected outcomes it produces, 
the research should allow WHO and Partnership donors 
to improve the Partnership content, to adapt it better 
to the contexts in which it is implemented, and to tailor 
the nature of the policy dialogue support to take into 
account the diverse influences that foster or undermine 
productive collaboration among stakeholders. This more 
constructive collaboration should in turn contribute to 
more robust and actionable health policies, as a means 
to strengthen health systems so that they can deliver the 
quality and affordable health services users are entitled to 
under the banner of UHC.
Second, the realist evaluation has been little used to 
study interventions on an international scale. Thus, this 
study will be a unique example in health policy and 
systems research, and will offer important methodological 
lessons. Furthermore, it entails the training and ongoing 
supervision of a team of West African researchers coming 
from various educational backgrounds and with different 
expertise. This project will help strengthen capacities in 
health policy and systems research in LMICs.
Finally, in terms of the topics addressed, the nature of 
the knowledge produced will be unique and will provide 
a deeper understanding of the issues associated with 
interventions aimed to support policy dialogue. As such, 
it adds to the findings on policy dialogue reported in the 
BMC Health Services Research special issue.40
dissemination of results
The results of the study will be disseminated on several 
levels: WHO, including the headquarters, the regional 
teams and the country teams; WHO’s national and inter-
national partners, particularly MoH and donors; and 
the scientific community. With regards to the scientific 
community, empirical findings and methodological issues 
will be shared in related symposia and in peer-reviewed 
journals. Any intention to publish the findings must be 
approved by WHO before submitting to the journal.
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